Temporal development of baroreceptor dysfunction in a rodent model of chronic kidney disease

Clinical and Experimental Pharmacology and Physiology

Volumn 40, Issue 7, 2013, Pages 458-465

  Hildreth, Cara M ^a   Kandukuri, Divya Sarma ^a   Goodchild, Ann K ^a   Phillips, Jacqueline K ^a  

^a MACQUARIE UNIVERSITY   (Australia)

Author keywords

Baroreflex; Heart rate variability; Polycystic kidney disease; Systolic blood pressure variability; Telemetry

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTONOMIC DYSFUNCTION; CARDIOVASCULAR MORTALITY; CHRONIC KIDNEY DISEASE; CIRCADIAN RHYTHM; CONTROLLED STUDY; HEART RATE VARIABILITY; KIDNEY POLYCYSTIC DISEASE; NONHUMAN; PRESSORECEPTOR; RAT; REDUCTION; SYSTOLIC BLOOD PRESSURE; TELEMETRY;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; BAROREFLEX; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; DISEASE MODELS, ANIMAL; HEART RATE; MALE; POLYCYSTIC KIDNEY DISEASES; PRESSORECEPTORS; RATS; RATS, INBRED LEW; RENAL INSUFFICIENCY, CHRONIC;

EID: 84879518075     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12110     Document Type: Article

References (43)

1. Chanda R, Fenves AZ. Hypertension in patients with chronic kidney disease. Curr. Hypertens. Rep. 2009; 11: 329-36.
2. Klein IH, Ligtenberg G, Neumann J, Oey PL, Koomans HA, Blankestijn PJ. Sympathetic nerve activity is inappropriately increased in chronic renal disease. J. Am. Soc. Nephrol. 2003; 14: 3239-44.
3. Klein IH, Ligtenberg G, Oey PL, Koomans HA, Blankestijn PJ. Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension. J. Am. Soc. Nephrol. 2001; 12: 2427-33.
4. Johansson M, Gao SA, Friberg P et al. Baroreflex effectiveness index and baroreflex sensitivity predict all-cause mortality and sudden death in hypertensive patients with chronic renal failure. J. Hypertens. 2007; 25: 163-8.
5. Task Force of the European Society of Cardiology, the North American Society of Pacing Electrophysiology. Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Circulation 1996; 93: 1043-65.
6. Stauss HM. Heart rate variability. Am. J. Physiol. Regul. Intergr. Comp. Physiol. 2003; 285: R927-31.
7. Pagani M, Lucini D, Rimoldi O et al. Low and high frequency components of blood pressure variability. Ann. N.Y. Acad. Sci. 1996; 783: 10-23.
8. Stauss HM. Identification of blood pressure control mechanisms by power spectral analysis. Clin. Exp. Pharmacol. Physiol. 2007; 34: 362-8.
9. Fukuta H, Hayano J, Ishihara S et al. Prognostic value of heart rate variability in patients with end-stage renal disease on chronic haemodialysis. Nephrol. Dial. Transplant. 2003; 18: 318-25.
10. Tozawa M, Iseki K, Yoshi S, Fukiyama K. Blood pressure variability as an adverse prognostic risk factor in end-stage renal disease. Nephrol. Dial. Transplant. 1999; 14: 1976-81.
11. Chandra P, Sands RL, Gillespie BW et al. Predictors of heart rate variability and its prognostic significance in chronic kidney disease. Nephrol. Dial. Transplant. 2012; 27: 700-9.
12. McCooke JK, Appels R, Barrero RA et al. A novel mutation causing nephronophthisis in the Lewis polycystic kidney rat localises to a conserved rcc1 domain in nek8. BMC Genomics 2012; 13: 393.
13. Phillips JK, Hopwood D, Loxley RA et al. Temporal relationship between renal cyst development, hypertension and cardiac hypertrophy in a new rat model of autosomal recessive polycystic kidney disease. Kidney Blood Press. Res. 2007; 30: 129-44.
14. Harrison JL, Hildreth CM, Callahan SM, Goodchild AK, Phillips JK. Cardiovascular autonomic dysfunction in a novel rodent model of polycystic kidney disease. Auton. Neurosci. 2010; 152: 60-6.
15. Hildreth CM, Padley JR, Pilowsky PM, Goodchild AK. Impaired serotonergic regulation of heart rate may underlie reduced baroreflex sensitivity in an animal model of depression. Am. J. Physiol. Heart Circ. Physiol. 2008; 294: H474-80.
16. Hildreth CM, Goodchild AK, Phillips JK. Insight into autonomic nervous system control of heart rate in the rat using analysis of heart rate variability and baroreflex sensitivity. In: Pilowsky PM, Farnham MMJ, Fong AY (eds). Stimulation and Inhibition of Neurons. Humana Press, New York, NY. 2013; 203-23.
17. Bidani AK, Griffin KA, Picken M, Lansky DM. Continuous telemetric blood pressure monitoring and glomerular injury in the rat remnant kidney model. Am. J. Physiol. 1993; 265: F391-8.
18. El-Mas MM, Abdel-Rahman AA. Longitudinal studies on the effect of hypertension on circadian and autonomic rhythms in telemetered rats. Life Sci. 2005; 76: 901-15.
19. Mancia G, Ferrari A, Pomidossi G et al. Twenty-four-hour blood pressure profile and blood pressure variability in untreated hypertension and during antihypertensive treatment by once-a-day nadolol. Am. Heart J. 1984; 108: 1078-83.
20. Jacob HJ, Ramanthan A, Pan SG, Brody MJ, Myers GA. Spectral analysis of arterial pressure lability in rats with sinoaortic deafferentation. Am. J. Physiol. 1995; 269: R1481-8.
21. Cerutti C, Barres C, Paultre C. Baroreflex modulation of blood pressure and heart rate variabilities in rats: Assessment by spectral analysis. Am. J. Physiol. 1994; 266: H1993-2000.
22. Ng K, Hildreth CM, Avolio AP, Phillips JK. Angiotensin-converting enzyme inhibitor limits pulse-wave velocity and aortic calcification in a rat model of cystic renal disease. Am. J. Physiol. Renal Physiol. 2011; 301: F959-66.
23. Vita G, Bellinghieri G, Trusso A et al. Uremic autonomic neuropathy studied by spectral analysis of heart rate. Kidney Int. 1999; 56: 232-7.
24. Rubinger D, Backenroth R, Sapoznikov D. Restoration of baroreflex function in patients with end-stage renal disease after renal transplantation. Nephrol. Dial. Transplant. 2009; 24: 1305-13.
25. Brotman DJ, Bash LD, Qayyum R et al. Heart rate variability predicts ESRD and CKD-related hospitalization. J. Am. Soc. Nephrol. 2010; 21: 1560-70.
26. Struyker-Boudier HA, Evenwel RT, Smits JF, Van Essen H. Baroreflex sensitivity during the development of spontaneous hypertension in rats. Clin. Sci. 1982; 62: 589-94.
27. Janssen BJ, van Essen H, Vervoort-Peters LH, Struyker-Boudier HA, Smits JF. Role of afferent renal nerves in spontaneous hypertension in rats. Hypertension 1989; 13: 327-33.
28. Lacy P, Carr SJ, O'Brien D et al. Reduced glomerular filtration rate in pre-dialysis non-diabetic chronic kidney disease patients is associated with impaired baroreceptor sensitivity and reduced vascular compliance. Clin. Sci. 2006; 110: 101-8.
29. Bavanandan S, Ajayi S, Fentum B, Paul SK, Carr SJ, Robinson TG. Cardiac baroreceptor sensitivity: A prognostic marker in predialysis chronic kidney disease patients. Kidney Int. 2005; 67: 1019-27.
30. Berenguer LM, Garcia-Estan J, Ubeda M, Ortiz AJ, Quesada T. Role of renin-angiotensin system in the impairment of baroreflex control of heart rate in renal hypertension. J. Hypertens. 1991; 9: 1127-33.
31. Agarwal A, Anand IS, Sakhuja V, Chugh KS. Effect of dialysis and renal transplantation on autonomic dysfunction in chronic renal failure. Kidney Int. 1991; 40: 489-95.
32. Gao SA, Johansson M, Hammaren A, Nordberg M, Friberg P. Reproducibility of methods for assessing baroreflex sensitivity and temporal QT variability in end-stage renal disease and healthy subjects. Clin. Auton. Res. 2005; 15: 21-8.
33. Studinger P, Lenard Z, Mersich B, Reusz GS, Kollai M. Determinants of baroreflex function in juvenile end-stage renal disease. Kidney Int. 2006; 69: 2236-42.
34. Gerhardt U, Riedasch M, Steinmetz M, Hohage H. Kidney transplantation improves baroreceptor sensitivity. Int. J. Cardiol. 1999; 70: 233-9.
35. Pickering TG, Gribbin B, Oliver DO. Baroreflex sensitivity in patients on long-term haemodialysis. Clin. Sci. 1972; 43: 645-57.
36. Lazarus JM, Hampers CL, Lowrie EG, Merrill JP. Baroreceptor activity in normotensive and hypertensive uremic patients. Circulation 1973; 47: 1015-21.
37. Johansson M, Gao SA, Friberg P et al. Reduced baroreflex effectiveness index in hypertensive patients with chronic renal failure. Am. J. Hypertens. 2005; 18: 995-1000.
38. Ng K, Hildreth CM, Phillips JK, Avolio AP. Aortic stiffness is associated with vascular calcification and remodeling in a chronic kidney disease rat model. Am. J. Physiol. Renal Physiol. 2011; 300: F1431-6.
39. Chesterton LJ, Sigrist MK, Bennett T, Taal MW, McIntyre CW. Reduced baroreflex sensitivity is associated with increased vascular calcification and arterial stiffness. Nephrol. Dial. Transplant. 2005; 20: 1140-7.
40. Hildreth CM, Goodchild AK. Role of ionotropic GABA, glutamate and glycine receptors in the tonic and reflex control of cardiac vagal outflow in the rat. BMC Neurosci. 2010; 11: 128.
41. Ohta H, Talman WT. Both nmda and non-nmda receptors in the nts participate in the baroreceptor reflex in rats. Am. J. Physiol. 1994; 267: R1065-70.
42. US Renal Data System. USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-stage Renal Disease in the United States. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. 2011.
43. Herzog CA. Cardiac arrest in dialysis patients: Approaches to alter an abysmal outcome. Kidney Int. Suppl. 2003; 63: S197-200.